Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Medical Oncology
•
Neurology
What experience do you have with paralysis or myasthenia like symptoms developing on Temozolomide?
Related Questions
In what circumstances would you consider use of IDH inhibitors in high-grade astrocytomas?
What approach do you use when treating adult diffuse gliomas with H3-G34 mutations, now classified into their own category under the 2021 glioma guidelines?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
Are you offering Lutathera for multiple recurrent meningiomas?
How do you counsel glioblastoma multiforme patients on which types of clinical trials to pursue?
How well does a negative non-contrast MRI of the brain exclude metastasis in a patient with squamous cell carcinoma of the lung?
Is there a role for bevacizimab (IV or IA) for steroid refractory radionecrosis for AVM?
What are the best radiation therapy options for a young adult with 3 brain metastases from myeloid sarcoma that hasn’t responded well to intrathecal therapy?
Do you utilize tumor treating fields in patients with anaplastic Pleomorphic Xanthoastrocytoma PXA III?
